"オミクロン" の関連情報検索結果

Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design - Duke University School of Medicine



Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design  Duke University School of Medicine

Computationally restoring the potency of a clinical antibody against Omicron - Nature.com



Computationally restoring the potency of a clinical antibody against Omicron  Nature.com

3 Things to Know About XEC, the Latest COVID Strain - Yale Medicine



3 Things to Know About XEC, the Latest COVID Strain  Yale Medicine

Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination - The Lancet



Humoral immunity after mRNA SARS-CoV-2 omicron JN.1 vaccination  The Lancet

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras - nejm.org



Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras  nejm.org

COVID-19 Variant Update - IDSA



COVID-19 Variant Update  IDSA

KP.3.1.1 is the Predominant Variant as COVID-19 Activity Increases - CDC



KP.3.1.1 is the Predominant Variant as COVID-19 Activity Increases  CDC

Repeated Omicron exposures redirect SARS-CoV-2–specific memory B cell evolution toward the latest...



Repeated Omicron exposures redirect SARS-CoV-2–specific memory B cell evolution toward the latest variants  Science

Omicron Epsilon Chapter introduces Divine Nine on Feature Phoenix - Today at Elon



Omicron Epsilon Chapter introduces Divine Nine on Feature Phoenix  Today at Elon

Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial - Natu...



Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial  Nature.com

Durability of XBB.1.5 Vaccines against Omicron Subvariants - nejm.org



Durability of XBB.1.5 Vaccines against Omicron Subvariants  nejm.org

Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later ...



Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later Omicron subvariants  Science

An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized tr...



An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial  Nature.com

An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation - Natur...



An ancestral SARS-CoV-2 vaccine induces anti-Omicron variants antibodies by hypermutation  Nature.com

Long-term effects of Omicron BA.2 breakthrough infection on immunity-metabolism balance: a 6-mont...



Long-term effects of Omicron BA.2 breakthrough infection on immunity-metabolism balance: a 6-month prospective study  Nature.com

Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and ...



Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations  Nature.com

A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16,...



A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16, BQ.1.1 and sarbecoviruses  Nature.com

Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutra...



Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies | Signal Transduction and Targeted Therapy  Nature.com

High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Ga...



High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia  Nature.com

Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population...



Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population  Nature.com

Association of pre-existing depression and anxiety with Omicron variant infection | Molecular Psy...



Association of pre-existing depression and anxiety with Omicron variant infection | Molecular Psychiatry  Nature.com

Detection of co-infection and recombination cases with Omicron and local Delta variants of SARS-C...



Detection of co-infection and recombination cases with Omicron and local Delta variants of SARS-CoV-2 in Vietnam  Nature.com

Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for...



Vaccination impairs de novo immune response to omicron breakthrough infection, a precondition for the original antigenic sin  Nature.com

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitnes...



Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion  Nature.com

Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children...



Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial  The Lancet

Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough in...



Heterogeneous hybrid immunity against Omicron variant JN.1 at 11 months following breakthrough infection  Nature.com

Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters | Communications Biol...



Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters | Communications Biology  Nature.com

Comparative SARS-CoV-2 Omicron BA.5 variant and D614G-Wuhan strain infections in ferrets: insight...



Comparative SARS-CoV-2 Omicron BA.5 variant and D614G-Wuhan strain infections in ferrets: insights into attenuation and disease progression during subclinical to mild COVID-19  Frontiers

The Updated COVID Vaccines Are Here: 9 Things to Know - Yale Medicine



The Updated COVID Vaccines Are Here: 9 Things to Know  Yale Medicine

Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants - Nature.com



Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants  Nature.com

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant - Nature.com



Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant  Nature.com

Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal...



Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue  Nature.com

FLiRTing with a COVID summer surge? What to know about the newest family of Omicron subvariants -...



FLiRTing with a COVID summer surge? What to know about the newest family of Omicron subvariants  Fortune

JN.1 Omicron subvariant: Questions patients may have - American Medical Association



JN.1 Omicron subvariant: Questions patients may have  American Medical Association

Effectiveness of nirmatrelvir/ritonavir in children and adolescents aged 12–17 years following SA...



Effectiveness of nirmatrelvir/ritonavir in children and adolescents aged 12–17 years following SARS-CoV-2 Omicron infection: A target trial emulation  Nature.com

Enhanced Surface Accessibility of SARS-CoV-2 Omicron Spike Protein Due to an Altered Glycosylatio...



Enhanced Surface Accessibility of SARS-CoV-2 Omicron Spike Protein Due to an Altered Glycosylation Profile  ACS Publications

Molecular characterization of SARS-CoV-2 Omicron clade and clinical presentation in children - Na...



Molecular characterization of SARS-CoV-2 Omicron clade and clinical presentation in children  Nature.com

Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants aft...



Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients  Nature.com

Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and ado...



Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China  Nature.com

The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its im...



The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis  Nature.com

New Covid Variants: Symptoms May Show Up In This Order - Healthline



New Covid Variants: Symptoms May Show Up In This Order  Healthline

Omicron Infection Timeline: When Symptoms Start and How Long They Last - Health.com



Omicron Infection Timeline: When Symptoms Start and How Long They Last  Health.com

Augmentation of Omicron BA.1 pathogenicity in hamsters using intratracheal inoculation - Nature.com



Augmentation of Omicron BA.1 pathogenicity in hamsters using intratracheal inoculation  Nature.com

Forecasting the spread of COVID-19 based on policy, vaccination, and Omicron data - Nature.com



Forecasting the spread of COVID-19 based on policy, vaccination, and Omicron data  Nature.com

Rapid and extensive SARS-CoV-2 Omicron variant infection wave revealed by wastewater surveillance...



Rapid and extensive SARS-CoV-2 Omicron variant infection wave revealed by wastewater surveillance in Shenzhen following the lifting of a strict COVID-19 strategy  ScienceDirect.com

Omicron Delta Kappa inducts 43 new members - UKNow



Omicron Delta Kappa inducts 43 new members  UKNow

New COVID strain is circulating in the US, what to know about the XEC variant - El Paso Times



New COVID strain is circulating in the US, what to know about the XEC variant  El Paso Times

Epidemiological and clinical features of SARS-CoV-2 Omicron variant infection in Quanzhou, Fujian...



Epidemiological and clinical features of SARS-CoV-2 Omicron variant infection in Quanzhou, Fujian province: a retrospective study  Nature.com

Omicron-specific and bivalent omicron-containing vaccine candidates elicit potent virus neutralis...



Omicron-specific and bivalent omicron-containing vaccine candidates elicit potent virus neutralisation in the animal model  Nature.com

Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) ... - CDC



Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) ...  CDC

Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting - Nature.com



Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting  Nature.com

Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19...



Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants  Nature.com

What Is Omicron’s Incubation Period? - Verywell Health



What Is Omicron’s Incubation Period?  Verywell Health

What to Know About COVID FLiRT Variants - Johns Hopkins Bloomberg School of Public Health



What to Know About COVID FLiRT Variants  Johns Hopkins Bloomberg School of Public Health

What Doctors Want You to Know About XEC, the New COVID-19 Variant - Prevention Magazine



What Doctors Want You to Know About XEC, the New COVID-19 Variant  Prevention Magazine

Omicron Symptoms Day by Day - Health. Powered by Ada.



Omicron Symptoms Day by Day  Health. Powered by Ada.

Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infecti...



Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children  Nature.com

COVID, flu severity similar, but Omicron BA.5 patients more likely to die, 2021-22 study suggests...



COVID, flu severity similar, but Omicron BA.5 patients more likely to die, 2021-22 study suggests  University of Minnesota Twin Cities

Africa CDC calls for more COVID-19 vaccination uptake amid Omicron variant worrying surge - afric...



Africa CDC calls for more COVID-19 vaccination uptake amid Omicron variant worrying surge  africacdc.org

JN.1, the Dominant Variant in the COVID Surge - Johns Hopkins Bloomberg School of Public Health



JN.1, the Dominant Variant in the COVID Surge  Johns Hopkins Bloomberg School of Public Health

Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent v...



Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent vaccine in infection-naive and XBB-infected individuals  The Lancet

3 Things to Know About JN.1, the New Coronavirus Strain - Yale Medicine



3 Things to Know About JN.1, the New Coronavirus Strain  Yale Medicine

Scientists identify antibodies that can neutralize Omicron - UW Medicine Newsroom



Scientists identify antibodies that can neutralize Omicron  UW Medicine Newsroom

SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode - Nat...



SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode  Nature.com

SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread - Nature.com



SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread  Nature.com

Prospective Validation of a Simple Risk Score to Predict Hospitalization during the Omicron Phase...



Prospective Validation of a Simple Risk Score to Predict Hospitalization during the Omicron Phase of COVID-19  Journal of the American Board of Family Medicine

Detection of SARS-CoV-2 and Omicron variant RNA in wastewater samples from Manila, Philippines - ...



Detection of SARS-CoV-2 and Omicron variant RNA in wastewater samples from Manila, Philippines  ScienceDirect.com

Omicron, Delta, Alpha, and More: What To Know About the Coronavirus Variants - Yale Medicine



Omicron, Delta, Alpha, and More: What To Know About the Coronavirus Variants  Yale Medicine

Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not...



Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants  Nature.com

Vaccines and virus changes cut long COVID risk by 50%, but Omicron still poses a threat - News-Me...



Vaccines and virus changes cut long COVID risk by 50%, but Omicron still poses a threat  News-Medical.Net

Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86 - ScienceDirect.com



Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86  ScienceDirect.com

An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicro...



An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants  Nature.com

Omicron and its Subvariants: A Guide to What We Know - Yale Medicine



Omicron and its Subvariants: A Guide to What We Know  Yale Medicine

How Many Days After COVID-19 Exposure Will I Get Symptoms? - Verywell Health



How Many Days After COVID-19 Exposure Will I Get Symptoms?  Verywell Health

New insights on antibody responses to Omicron variants - UW Medicine Newsroom



New insights on antibody responses to Omicron variants  UW Medicine Newsroom

Nirmatrelvir/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection: a target trial em...



Nirmatrelvir/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection: a target trial emulation  Nature.com

WHO roadmap on uses of COVID-19 vaccines in the context of Omicron and high population immunity -...



WHO roadmap on uses of COVID-19 vaccines in the context of Omicron and high population immunity  World Health Organization (WHO)

Epidemiological and laboratory characteristics of Omicron infection in a general hospital in Guan...



Epidemiological and laboratory characteristics of Omicron infection in a general hospital in Guangzhou: a retrospective study  Frontiers

Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern - World Health Organization ...



Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern  World Health Organization (WHO)

Enhancing response to Omicron SARS-CoV-2 variant - World Health Organization (WHO)



Enhancing response to Omicron SARS-CoV-2 variant  World Health Organization (WHO)

COVID-19 vaccines induce immune response to Omicron - National Institutes of Health (NIH) (.gov)



COVID-19 vaccines induce immune response to Omicron  National Institutes of Health (NIH) (.gov)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection - nejm.org



Protection against the Omicron Variant from Previous SARS-CoV-2 Infection  nejm.org

Current Covid vaccines 'might not protect' against new XEC variant - My London



Current Covid vaccines 'might not protect' against new XEC variant  My London

Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave - N...



Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave  Nature.com

A Bivalent Omicron-Containing Booster Vaccine against Covid-19 - nejm.org



A Bivalent Omicron-Containing Booster Vaccine against Covid-19  nejm.org

One year since the emergence of COVID-19 virus variant Omicron - World Health Organization (WHO)



One year since the emergence of COVID-19 virus variant Omicron  World Health Organization (WHO)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination - nejm.org



SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination  nejm.org

The Omicron Booster: Your Questions Answered - Yale Medicine



The Omicron Booster: Your Questions Answered  Yale Medicine

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants - Na...



BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants  Nature.com

Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa - nejm.org



Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa  nejm.org

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution - Nature.com



Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution  Nature.com

Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time - National Institutes of...



Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time  National Institutes of Health (NIH) (.gov)

Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant - nejm.org



Challenges in Inferring Intrinsic Severity of the SARS-CoV-2 Omicron Variant  nejm.org

XBB.1.5 Omicron subvariant: Questions patients may have - American Medical Association



XBB.1.5 Omicron subvariant: Questions patients may have  American Medical Association

Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies - Natu...



Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies  Nature.com

Effectiveness of the second COVID-19 booster against Omicron: a large-scale cohort study in Chile...



Effectiveness of the second COVID-19 booster against Omicron: a large-scale cohort study in Chile  Nature.com

Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge - nejm.org



Nirmatrelvir Use and Severe Covid-19 Outcomes during the Omicron Surge  nejm.org

SARS-CoV-2 Omicron boosting induces de novo B cell response in humans - Nature.com



SARS-CoV-2 Omicron boosting induces de novo B cell response in humans  Nature.com

BNT162b2 Protection against the Omicron Variant in Children and Adolescents - nejm.org



BNT162b2 Protection against the Omicron Variant in Children and Adolescents  nejm.org

Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants - Nat...



Post-covid medical complaints following infection with SARS-CoV-2 Omicron vs Delta variants  Nature.com